RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,687 | +8.6% | 115,229 | -11.0% | 0.00% | – |
| Q2 2023 | $318,395 | -74.4% | 129,429 | -76.5% | 0.00% | – |
| Q1 2023 | $1,245,477 | -64.0% | 551,096 | -44.4% | 0.00% | – |
| Q4 2022 | $3,460,216 | -84.2% | 991,466 | +68.0% | 0.00% | -100.0% |
| Q3 2022 | $21,847,000 | +91.4% | 590,134 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $11,417,000 | -5.1% | 601,185 | +34.9% | 0.00% | 0.0% |
| Q1 2022 | $12,026,000 | +65.1% | 445,564 | +37.8% | 0.00% | – |
| Q4 2021 | $7,286,000 | -14.7% | 323,401 | -0.8% | 0.00% | – |
| Q3 2021 | $8,541,000 | -14.0% | 325,871 | +5.1% | 0.00% | -100.0% |
| Q2 2021 | $9,928,000 | -3.0% | 310,164 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $10,231,000 | +4.8% | 290,585 | -4.6% | 0.00% | 0.0% |
| Q4 2020 | $9,764,000 | -14.1% | 304,459 | +0.7% | 0.00% | 0.0% |
| Q3 2020 | $11,373,000 | -10.8% | 302,321 | +6.2% | 0.00% | 0.0% |
| Q2 2020 | $12,744,000 | +4340.4% | 284,771 | +3290.1% | 0.00% | – |
| Q1 2020 | $287,000 | – | 8,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |